Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
11.6M
-
Shares change
-
+464K
-
Total reported value, excl. options
-
$96.9M
-
Value change
-
+$6.09M
-
Put/Call ratio
-
0.4
-
Number of buys
-
40
-
Number of sells
-
-23
-
Price
-
$8.35
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2016
89 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2016.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.6M shares
of 54.8M outstanding shares and own 21.19% of the company stock.
Largest 10 shareholders include RHO CAPITAL PARTNERS INC (3.07M shares), BlackRock Fund Advisors (954K shares), VANGUARD GROUP INC (723K shares), Opaleye Management Inc. (675K shares), FRANKLIN RESOURCES INC (611K shares), BlackRock Institutional Trust Company, N.A. (551K shares), Allianz Asset Management GmbH (378K shares), JPMORGAN CHASE & CO (370K shares), STATE STREET CORP (325K shares), and CAM Group Holding A/S (268K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.